CLOROX CO /DE/ Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2017-09-14: Study NCT03201068; Company role Collaborator; Phase Not applicable; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2017-09-14 | NCT03201068 Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome | Collaborator Lead: Stanford University | Not applicable | Completed | Metabolic Syndrome; Microbiome; Immune Function; Inflammation | 42 | 2018-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zone Frontier Inc. (ZONE) | United States | $0.030B |